Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference The new mini-textbook by Kamps & Hoffmann PDF, 110 pages

Lung Cancer

Free Subscription Articles published in Cancer Epidemiol Biomarkers Prev Retrieve available abstracts of 31 articles: HTML format Text format

Single Articles

April 2020
1. WEI Q, Deng W, Liu H, Luo S, et al
   APOB genotypes and CDH13 haplotypes in the cholesterol-related pathway genes predict non-small cell lung cancer survival.
   Cancer Epidemiol Biomarkers Prev. 2020 Apr 1. pii: 1055-9965.EPI-19-1262.
   PubMed     Text format     Abstract available
   
   
   December 2019
2. CHIEN LH, Chen CH, Chen TY, Chang GC, et al
   Predicting lung cancer occurrence in never-smoking females in Asia: TNSF-SQ, a prediction model.
   Cancer Epidemiol Biomarkers Prev. 2019 Dec 17. pii: 1055-9965.EPI-19-1221.
   PubMed     Text format     Abstract available
   
   
   
3. MUSOLF AM, Moiz BA, Sun H, Pikielny CW, et al
   Whole Exome Sequencing of Highly Aggregated Lung Cancer Families Reveals Linked Loci for Increased Cancer Risk on Chromosomes 12q, 7p and 4q.
   Cancer Epidemiol Biomarkers Prev. 2019 Dec 11. pii: 1055-9965.EPI-19-0887.
   PubMed     Text format     Abstract available
   
   
   November 2019
4. THOMAS CE, Wang R, Adams-Haduch J, Murphy SE, et al
   Urinary cotinine is as good a biomarker as serum cotinine for cigarette smoking exposure and lung cancer risk prediction.
   Cancer Epidemiol Biomarkers Prev. 2019 Nov 4. pii: 1055-9965.EPI-19-0653.
   PubMed     Text format     Abstract available
   
   
   October 2019
5. UDUMYAN R, Montgomery S, Fang F, Valdimarsdottir U, et al
   Beta-blocker use and lung cancer mortality in a nationwide cohort study of patients with primary non-small cell lung cancer.
   Cancer Epidemiol Biomarkers Prev. 2019 Oct 22. pii: 1055-9965.EPI-19-0710.
   PubMed     Text format     Abstract available
   
   
   
6. SCHABATH MB, Cote ML
   Cancer Progress and Priorities: Lung Cancer.
   Cancer Epidemiol Biomarkers Prev. 2019;28:1563-1579.
   PubMed     Text format    
   
   
   September 2019
7. D'ANTONA P, Cattoni M, Dominioni L, Poli A, et al
   Serum miR-223: a validated biomarker for detection of early-stage non-small cell lung cancer.
   Cancer Epidemiol Biomarkers Prev. 2019 Sep 5. pii: 1055-9965.EPI-19-0626.
   PubMed     Text format     Abstract available
   
   
   July 2019
8. KACHURI L, Helby J, Bojesen SE, Christiani DC, et al
   Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer.
   Cancer Epidemiol Biomarkers Prev. 2019;28:1228-1237.
   PubMed     Text format     Abstract available
   
   
   April 2019
9. HUO J, Hong YR, Bian J, Guo Y, et al
   Low Rates of Patient-Reported Physician-Patient Discussion about Lung Cancer Screening among Current Smokers: Data from Health Information National Trends Survey.
   Cancer Epidemiol Biomarkers Prev. 2019 Apr 25. pii: 1055-9965.EPI-18-0629.
   PubMed     Text format     Abstract available
   
   
   
10. GRAFETSTATTER M, Husing A, Gonzalez Maldonado S, Sookthai D, et al
    Plasma Fibrinogen and sP-Selectin are associated with the risk of lung cancer in a prospective study.
    Cancer Epidemiol Biomarkers Prev. 2019 Apr 23. pii: 1055-9965.EPI-18-1285.
    PubMed     Text format     Abstract available
    
    
    March 2019
11. JONES CC, Bradford Y, Amos CI, Blot WJ, et al
    Cross-cancer pleiotropic associations with lung cancer risk in African Americans.
    Cancer Epidemiol Biomarkers Prev. 2019 Mar 20. pii: 1055-9965.EPI-18-0935.
    PubMed     Text format     Abstract available
    
    
    
12. MAGUIRE FB, Morris CR, Parikh-Patel A, Cress RD, et al
    Disparities in systemic treatment use in advanced-stage non-small cell lung cancer by source of health insurance.
    Cancer Epidemiol Biomarkers Prev. 2019 Mar 6. pii: 1055-9965.EPI-18-0823.
    PubMed     Text format     Abstract available
    
    
    February 2019
13. PALAZZO LL, Sheehan DF, Tramontano AC, Kong CY, et al
    Disparities and Trends in Rates of Genetic Testing and Erlotinib Treatment Among Metastatic Non-Small Cell Lung Cancer Patients.
    Cancer Epidemiol Biomarkers Prev. 2019 Feb 20. pii: 1055-9965.EPI-18-0917.
    PubMed     Text format     Abstract available
    
    
    
14. PETERS BA, Hayes RB, Goparaju C, Reid C, et al
    The microbiome in lung cancer tissue and recurrence-free survival.
    Cancer Epidemiol Biomarkers Prev. 2019 Feb 7. pii: 1055-9965.EPI-18-0966.
    PubMed     Text format     Abstract available
    
    
    January 2019
15. ZHU Y, Wei Y, Zhang R, Dong X, et al
    Elevated platelet count appears to be causally associated with increased risk of lung cancer: A Mendelian randomization analysis.
    Cancer Epidemiol Biomarkers Prev. 2019 Jan 30. pii: 1055-9965.EPI-18-0356.
    PubMed     Text format     Abstract available
    
    
    
16. LUSK CM, Wenzlaff AS, Watza D, Sieren JC, et al
    Quantitative imaging markers of lung function in a smoking population distinguish COPD sub-groups with differential lung cancer risk.
    Cancer Epidemiol Biomarkers Prev. 2019 Jan 14. pii: 1055-9965.EPI-18-0886.
    PubMed     Text format     Abstract available
    
    
    October 2018
17. NIU Y, Su M, Wu Y, Fu L, et al
    Circulating plasma microRNAs as potential biomarkers of non-small cell lung cancer obtained by high-throughput real-time PCR profiling.
    Cancer Epidemiol Biomarkers Prev. 2018 Oct 30. pii: 1055-9965.EPI-18-0723.
    PubMed     Text format     Abstract available
    
    
    
18. BROWN D, Zingone A, Yu Y, Zhu B, et al
    Relationship between circulating inflammation proteins and lung cancer diagnosis in the National Lung Screening Trial.
    Cancer Epidemiol Biomarkers Prev. 2018 Oct 8. pii: 1055-9965.EPI-18-0598.
    PubMed     Text format     Abstract available
    
    
    September 2018
19. GUO Y, Zhang R, Shen S, Wei Y, et al
    DNA Methylation of LRRC3B: A Biomarker for Survival of Early-Stage Non-Small Cell Lung Cancer Patients.
    Cancer Epidemiol Biomarkers Prev. 2018 Sep 5. pii: 1055-9965.EPI-18-0454.
    PubMed     Text format     Abstract available
    
    
    August 2018
20. ERICKSON P, Gardner LD, Loffredo CA, St George DM, et al
    Racial and Ethnic Differences in the Relationship Between Aspirin Use and Non-Small Cell Lung Cancer Risk and Survival.
    Cancer Epidemiol Biomarkers Prev. 2018 Aug 31. pii: 1055-9965.EPI-18-0366.
    PubMed     Text format     Abstract available
    
    
    May 2018
21. DOHERTY JA, Grieshober L, Houck JR, Barnett MJ, et al
    Telomere length and lung cancer mortality among heavy smokers.
    Cancer Epidemiol Biomarkers Prev. 2018 May 9. pii: 1055-9965.EPI-17-1183.
    PubMed     Text format     Abstract available
    
    
    March 2018
22. ROSS K, Kramer MR, Jemal A
    Geographic Inequalities in Progress against Lung Cancer among Women in the United States, 1990-2015.
    Cancer Epidemiol Biomarkers Prev. 2018 Mar 30. pii: 1055-9965.EPI-17-0934.
    PubMed     Text format     Abstract available
    
    
    
23. LIN J, Kamamia C, Brown D, Shao S, et al
    Survival among Lung Cancer Patients in the U.S. Military Health System: A Comparison with the SEER population.
    Cancer Epidemiol Biomarkers Prev. 2018 Mar 12. pii: 1055-9965.EPI-17-0822.
    PubMed     Text format     Abstract available
    
    
    January 2018
24. ZHAO Y, Varn FS, Cai G, Xiao F, et al
    A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma.
    Cancer Epidemiol Biomarkers Prev. 2018;27:86-95.
    PubMed     Text format     Abstract available
    
    
    October 2017
25. LUND JL, Sanoff HK, Peacock-Hinton S, Muss H, et al
    Potential Medication-Related Problems in Older Breast, Colon, and Lung Cancer Patients in the United States.
    Cancer Epidemiol Biomarkers Prev. 2017 Oct 4. pii: cebp.0523.2017.
    PubMed     Text format     Abstract available
    
    
    July 2017
26. ARGIRION I, Weinstein SJ, Mannisto S, Albanes D, et al
    Serum Insulin, Glucose, Indices of Insulin Resistance, and Risk of Lung Cancer.
    Cancer Epidemiol Biomarkers Prev. 2017 Jul 11. pii: cebp.0293.2017.
    PubMed     Text format     Abstract available
    
    
    June 2017
27. JONES CC, Bush WS, Crawford DC, Wenzlaff AS, et al
    Germline genetic variants and lung cancer survival in African Americans.
    Cancer Epidemiol Biomarkers Prev. 2017 Jun 15. pii: cebp.0998.2016.
    PubMed     Text format     Abstract available
    
    
    
28. BOSSE Y, Amos CI
    A decade of GWAS results in lung cancer.
    Cancer Epidemiol Biomarkers Prev. 2017 Jun 14. pii: cebp.0794.2016.
    PubMed     Text format     Abstract available
    
    
    April 2017
29. BOFFA DJ, Graf RP, Salazar MC, Hoag J, et al
    Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival.
    Cancer Epidemiol Biomarkers Prev. 2017 Apr 26. pii: cebp.0120.2017.
    PubMed     Text format     Abstract available
    
    
    
30. TORRE LA, Islami F, Siegel RL, Ward EM, et al
    Global Cancer in Women: Burden and Trends.
    Cancer Epidemiol Biomarkers Prev. 2017;26:444-457.
    PubMed     Text format     Abstract available
    
    
    March 2017
31. BOSSE Y, Sazonova O, Gaudreault N, Bastien N, et al
    Transcriptomic Microenvironment of Lung Adenocarcinoma.
    Cancer Epidemiol Biomarkers Prev. 2017;26:389-396.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: